UOK 268 Cell Line for Hereditary Leiomyomatosis and Renal Cell Carcinoma

therapoid

  1. Home
  2. Technologies
  3. UOK 268 Cell Line for Hereditary Leiomyomatosis and Renal Cell Carcinoma
  4. Summary
Provided by: National Institutes of Health (NIH)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology uses the UOK 262 immortalized cell line as research tool to study aggressive hereditary leiomyomatosis and renal cell carcinoma (HLRCC) associated with recurring kidney cancer.

Projects based on this Technology

Start New Project